Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.

Youngae JungMin Kyung LeePuneet PuriBo Kyung KooSae Kyung JooSeo Young JangDong Hyeon LeeYong Jin JungByeong Gwan KimKook Lae LeeTae-Sik ParkKi-Tae KangDo Hyun RyuSang Won KangDonghee KimSohee OhWon KimGeum-Sook Hwang

Published in: Alimentary pharmacology & therapeutics (2020)

Non-obese and obese NAFLD subjects exhibit unique circulating lipidomic signatures, including DAGs, TAGs and SMs. These lipid combinations may be useful biomarkers for non-obese and obese NAFLD patients.

Keyphrases

weight loss
adipose tissue
metabolic syndrome
type diabetes
obese patients
bariatric surgery
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
patient reported outcomes
fatty acid